Literature DB >> 23071249

Comparative effectiveness research in oncology: an overview.

Gary H Lyman1, Mark Levine.   

Abstract

Mesh：

Year:  2012        PMID： 23071249     DOI： 10.1200/JCO.2012.45.9792

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  16 in total

1.  The Cancer Research Network: a platform for epidemiologic and health services research on cancer prevention, care, and outcomes in large, stable populations.

Authors:  Jessica Chubak; Rebecca Ziebell; Robert T Greenlee; Stacey Honda; Mark C Hornbrook; Mara Epstein; Larissa Nekhlyudov; Pamala A Pawloski; Debra P Ritzwoller; Nirupa R Ghai; Heather Spencer Feigelson; Heather A Clancy; V Paul Doria-Rose; Lawrence H Kushi
Journal:  Cancer Causes Control       Date:  2016-09-17       Impact factor: 2.506

2.  Promoting the Appropriate Use of Advanced Radiation Technologies in Oncology: Summary of a National Cancer Policy Forum Workshop.

Authors:  Grace L Smith; Patricia A Ganz; Justin E Bekelman; Steven J Chmura; James J Dignam; Jason A Efstathiou; Reshma Jagsi; Peter A Johnstone; Michael L Steinberg; Stephen B Williams; James B Yu; Anthony L Zietman; Ralph R Weichselbaum; Ya-Chen Tina Shih
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-11-08       Impact factor: 7.038

Review 3.  Chemotherapy dosing in overweight and obese patients with cancer.

Authors:  Gary H Lyman; Alex Sparreboom
Journal:  Nat Rev Clin Oncol       Date:  2013-07-16       Impact factor: 66.675

4.  Comparative Effectiveness of Biomarkers to Target Cancer Treatment: Modeling Implications for Survival and Costs.

Authors:  Jeanette K Birnbaum; Foluso O Ademuyiwa; Josh J Carlson; Leslie Mallinger; Mark W Mason; Ruth Etzioni
Journal:  Med Decis Making       Date:  2015-08-24       Impact factor: 2.583

5.  Comparative effectiveness research in oncology.

Authors:  Gary H Lyman
Journal:  Oncologist       Date:  2013-05-22

Review 6.  Considerations for observational research using large data sets in radiation oncology.

Authors:  Reshma Jagsi; Justin E Bekelman; Aileen Chen; Ronald C Chen; Karen Hoffman; Ya-Chen Tina Shih; Benjamin D Smith; James B Yu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-09-01       Impact factor: 7.038

7.  Combining primary cohort data with external aggregate information without assuming comparability.

Authors:  Ziqi Chen; Jing Ning; Yu Shen; Jing Qin
Journal:  Biometrics       Date:  2020-08-25       Impact factor: 1.701

8.  Cost-utility analysis of treatments for stage IB cervical cancer.

Authors:  Kanyarat Katanyoo; Naiyana Praditsitthikorn; Siriwan Tangjitgamol; Sumonmal Manusirivithaya; Busaba Supawattanabodee
Journal:  J Gynecol Oncol       Date:  2014-04-09       Impact factor: 4.401

9.  Generating and evaluating evidence of the clinical utility of molecular diagnostic tests in oncology.

Authors:  Patricia Deverka; Donna A Messner; Robert McCormack; Gary H Lyman; Margaret Piper; Linda Bradley; David Parkinson; David Nelson; Howard L McLeod; Mary Lou Smith; Louis Jacques; Tania Dutta; Sean R Tunis
Journal:  Genet Med       Date:  2015-12-03       Impact factor: 8.822

10.  Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer.

Authors:  Clara Natoli; Patrizia Vici; Isabella Sperduti; Antonino Grassadonia; Giancarlo Bisagni; Nicola Tinari; Andrea Michelotti; Germano Zampa; Stefania Gori; Luca Moscetti; Michele De Tursi; Michele Panebianco; Maria Mauri; Ilaria Ferrarini; Laura Pizzuti; Corrado Ficorella; Riccardo Samaritani; Lucia Mentuccia; Stefano Iacobelli; Teresa Gamucci
Journal:  J Cancer Res Clin Oncol       Date:  2013-04-20       Impact factor: 4.553
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.